(Q45755917)

15 December 2017

title

Sclerostin as a new key player in arteriovenous fistula calcification (English)

1 reference

15 December 2017

main subject

arteriovenous fistula

1 reference

M Balcı

1

1 reference

15 December 2017

A Kırkpantur

2

1 reference

15 December 2017

A Turkvatan

3

1 reference

15 December 2017

S Mandıroglu

4

1 reference

15 December 2017

E Ozturk

5

1 reference

15 December 2017

B Afsar

6

1 reference

15 December 2017

publication date

19 October 2013

1 reference

15 December 2017

published in

Herz

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

2

1 reference

15 December 2017

page(s)

289-297

1 reference

15 December 2017

Vascular access and all-cause mortality: a propensity score analysis

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Hemodialysis vascular access dysfunction: a cellular and molecular viewpoint

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Regulation of bone mass by Wnt signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Sclerostin and Dickkopf-1 in renal osteodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

The appearance and modulation of osteocyte marker expression during calcification of vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Diagnostic accuracy of ultrasound dilution access blood flow measurement in detecting stenosis and predicting thrombosis in native forearm arteriovenous fistulae for hemodialysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Quantification of coronary artery calcium using ultrafast computed tomography.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Vascular calcification: pathobiological mechanisms and clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Risk equation determining unsuccessful cannulation events and failure to maturation in arteriovenous fistulas (REDUCE FTM I).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

The role of protein-bound uremic toxins on peripheral artery disease and vascular access failure in patients on hemodialysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

A comparative study of clinically well-characterized human atherosclerotic plaques with histological, chemical, and ultrastructural methods.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Msx2 promotes cardiovascular calcification by activating paracrine Wnt signals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Circulating sclerostin and Dickkopf-1 (DKK1) in predialysis chronic kidney disease (CKD): relationship with bone density and arterial stiffness

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Effects of parathyroid hormone treatment on circulating sclerostin levels in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Sclerostin: another bone-related protein related to all-cause mortality in haemodialysis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Sclerostin binds and regulates the activity of cysteine-rich protein 61.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Preexisting venous calcification prior to dialysis vascular access surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Accelerated "atherosclerosis". A morphologic study of 97 saphenous vein coronary artery bypass grafts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Association of serum lipid profile and arteriovenous fistula thrombosis in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

Relation of age, gender, and bone mass to circulating sclerostin levels in women and men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00059-013-3992-Y

[Prevalence and functional effect of arteriovenous fistula calcifications, evaluated by spiral CT in chronic haemodialysis patients].

21 January 2018

1 reference

12 December 2020

Microinflammation is involved in the dysfunction of arteriovenous fistula in patients with maintenance hemodialysis.

1 reference

12 December 2020

Evidence of calcium phosphate depositions in stenotic arteriovenous fistulas

1 reference

12 December 2020

The relation of risk factors to the development of atherosclerosis in saphenous-vein bypass grafts and the progression of disease in the native circulation. A study 10 years after aortocoronary bypass surgery

1 reference

12 December 2020

Increased expression of TGF-β1 and IGF-I in inflammatory stenotic lesions of hemodialysis fistulas

1 reference

12 December 2020

C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries

1 reference

12 December 2020

Sclerostin: Another vascular calcification inhibitor?

1 reference

12 December 2020

Vascular access calcification predicts mortality in hemodialysis patients

1 reference

12 December 2020

Hemodialysis vascular access morbidity.

1 reference

12 December 2020

Pre-existing histopathological changes in the cephalic vein of renal failure patients before arterio-venous fistula (AVF) construction

1 reference

12 December 2020

Sclerostin serum levels correlate positively with bone mineral density and microarchitecture in haemodialysis patients

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Sclerostin: just one more player in renal bone disease?

1 reference

12 December 2020

Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation

1 reference

12 December 2020

A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients

1 reference

12 December 2020

10.1007/S00059-013-3992-Y

Identifiers

DOI

1 reference

15 December 2017

PubMed ID

24135878

1 reference

15 December 2017